NOVÁKOVÁ, Tereza, Táňa MACHÁČKOVÁ, Jan NOVÁK, Petr HUDE, Július GODAVA, Víta ŽAMPACHOVÁ, Jan OPPELT, Filip ZLÁMAL, Petr NEMEC, Helena BEDANOVA, Ondřej SLABÝ, Julie DOBROVOLNÁ, Lenka ŠPINAROVÁ and Jan KREJČÍ. Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing. Cells. Basel: MDPI, 2019, vol. 8, No 11, p. 1-13. ISSN 2073-4409. Available from: https://dx.doi.org/10.3390/cells8111400.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing
Authors NOVÁKOVÁ, Tereza (203 Czech Republic, belonging to the institution), Táňa MACHÁČKOVÁ (203 Czech Republic, belonging to the institution), Jan NOVÁK (203 Czech Republic, belonging to the institution), Petr HUDE (203 Czech Republic, belonging to the institution), Július GODAVA (703 Slovakia, belonging to the institution), Víta ŽAMPACHOVÁ (203 Czech Republic, belonging to the institution), Jan OPPELT (203 Czech Republic, belonging to the institution), Filip ZLÁMAL (203 Czech Republic, belonging to the institution), Petr NEMEC (203 Czech Republic), Helena BEDANOVA (203 Czech Republic), Ondřej SLABÝ (203 Czech Republic, belonging to the institution), Julie DOBROVOLNÁ (203 Czech Republic, belonging to the institution), Lenka ŠPINAROVÁ (203 Czech Republic, belonging to the institution) and Jan KREJČÍ (203 Czech Republic, guarantor, belonging to the institution).
Edition Cells, Basel, MDPI, 2019, 2073-4409.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.366
RIV identification code RIV/00216224:14110/19:00108567
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/cells8111400
UT WoS 000502266700098
Keywords in English microRNA; endomyocardial biopsy; heart transplantation; acute cellular rejection; diagnostics
Tags 14110112, 14110115, 14110518, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/5/2020 12:21.
Abstract
Introduction: Acute cellular rejection (ACR) of heart allografts represents the most common reason for graft failure. Endomyocardial biopsies (EMB) are still subject to substantial interobserver variability. Novel biomarkers enabling precise ACR diagnostics may decrease interobserver variability. We aimed to identify a specific subset of microRNAs reflecting the presence of ACR. Patients and Methods: Monocentric retrospective study. A total of 38 patients with the anamnesis of ACR were identified and for each patient three consecutive samples of EMB (with, prior and after ACR) were collected. Sixteen trios were used for next-generation sequencing (exploratory cohort); the resting 22 trios were used for validation with qRT-PCR (validation cohort). Statistical analysis was performed using R software. Results: The analysis of the exploration cohort provided the total of 11 miRNAs that were altered during ACR, the three of which (miR-144, miR-589 and miR-182) were further validated in the validation cohort. Using the levels of all 11 miRNAs and principal component analysis, an ACR score was created with the specificity of 91% and sensitivity of 68% for detecting the presence of ACR in the EMB sample. Conclusion: We identified a set of microRNAs altered in endomyocardial biopsies during ACR and using their relative levels we created a diagnostic score that can be used for ACR diagnosis.
Links
MUNI/A/1553/2018, interní kód MUName: Genetické, environmentální a tkáňové charakteristiky vybraných patologických stavů a nemocí (Acronym: genetika; stres; biomateriály; tkáňové kultury)
Investor: Masaryk University, Category A
NV16-30537A, research and development projectName: Cirkulující mikroRNA jako neinvazivní markery rejekce štěpu u pacientů po srdeční transplantaci
PrintDisplayed: 28/5/2024 19:14